 | • レポートコード：GIR-2104Z00345 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アデノウイルスワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アデノウイルスワクチンの種類別市場規模（タイプ4ワクチン、タイプ7ワクチン）、用途別市場規模（研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アデノウイルスワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：タイプ4ワクチン、タイプ7ワクチン ・用途別分析2016年-2026年：研究所、製薬・バイオテクノロジー企業、その他 ・アデノウイルスワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アデノウイルスワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アデノウイルスワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アデノウイルスワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アデノウイルスワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Adenovirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Adenovirus Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Adenovirus Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Adenovirus Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Type 4 Vaccine
Type 7 Vaccine
Market segment by Application can be divided into
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Adenovirus Vaccine market are listed below:
Teva Pharmaceuticals
Barr Labs
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Adenovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adenovirus Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Type 4 Vaccine
1.2.3 Type 7 Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Adenovirus Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Global Adenovirus Vaccine Market Size & Forecast
1.4.1 Global Adenovirus Vaccine Sales in Value (2016-2026))
1.4.2 Global Adenovirus Vaccine Sales in Volume (2016-2026)
1.4.3 Global Adenovirus Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Adenovirus Vaccine Production Capacity Analysis
1.5.1 Global Adenovirus Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Adenovirus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Adenovirus Vaccine Market Drivers
1.6.2 Adenovirus Vaccine Market Restraints
1.6.3 Adenovirus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Teva Pharmaceuticals
2.1.1 Teva Pharmaceuticals Details
2.1.2 Teva Pharmaceuticals Major Business
2.1.3 Teva Pharmaceuticals Adenovirus Vaccine Product and Services
2.1.4 Teva Pharmaceuticals Adenovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Barr Labs
2.2.1 Barr Labs Details
2.2.2 Barr Labs Major Business
2.2.3 Barr Labs Adenovirus Vaccine Product and Services
2.2.4 Barr Labs Adenovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Adenovirus Vaccine Sales by Manufacturer
3.1 Global Adenovirus Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Adenovirus Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Adenovirus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Adenovirus Vaccine Manufacturer Market Share
3.4.2 Top 6 Adenovirus Vaccine Manufacturer Market Share
3.5 Global Adenovirus Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Adenovirus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Adenovirus Vaccine Market Size by Region
4.1.1 Global Adenovirus Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Adenovirus Vaccine Revenue by Region (2016-2026)
4.2 North America Adenovirus Vaccine Revenue (2016-2026)
4.3 Europe Adenovirus Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Adenovirus Vaccine Revenue (2016-2026)
4.5 South America Adenovirus Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Adenovirus Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Adenovirus Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Adenovirus Vaccine Revenue by Type (2016-2026)
5.3 Global Adenovirus Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Adenovirus Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Adenovirus Vaccine Revenue by Application (2016-2026)
6.3 Global Adenovirus Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Adenovirus Vaccine Sales by Type (2016-2026)
7.2 North America Adenovirus Vaccine Sales by Application (2016-2026)
7.3 North America Adenovirus Vaccine Market Size by Country
7.3.1 North America Adenovirus Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Adenovirus Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Adenovirus Vaccine Sales by Type (2016-2026)
8.2 Europe Adenovirus Vaccine Sales by Application (2016-2026)
8.3 Europe Adenovirus Vaccine Market Size by Country
8.3.1 Europe Adenovirus Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Adenovirus Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Adenovirus Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Adenovirus Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Adenovirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Adenovirus Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Adenovirus Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Adenovirus Vaccine Sales by Type (2016-2026)
10.2 South America Adenovirus Vaccine Sales by Application (2016-2026)
10.3 South America Adenovirus Vaccine Market Size by Country
10.3.1 South America Adenovirus Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Adenovirus Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Adenovirus Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Adenovirus Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Adenovirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Adenovirus Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Adenovirus Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Adenovirus Vaccine Typical Distributors
12.3 Adenovirus Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Adenovirus Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Adenovirus Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceuticals Major Business
Table 5. Teva Pharmaceuticals Adenovirus Vaccine Product and Services
Table 6. Teva Pharmaceuticals Adenovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Barr Labs Basic Information, Manufacturing Base and Competitors
Table 8. Barr Labs Major Business
Table 9. Barr Labs Adenovirus Vaccine Product and Services
Table 10. Barr Labs Adenovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Adenovirus Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 12. Global Adenovirus Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Adenovirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Adenovirus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Adenovirus Vaccine Production Site of Key Manufacturer
Table 16. Global Adenovirus Vaccine Sales by Region (2016-2021e) & (K Units)
Table 17. Global Adenovirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 18. Global Adenovirus Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Adenovirus Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Adenovirus Vaccine Sales by Type (2016-2021e) & (K Units)
Table 21. Global Adenovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 22. Global Adenovirus Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Adenovirus Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Adenovirus Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 25. Global Adenovirus Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 26. Global Adenovirus Vaccine Sales by Application (2016-2021e) & (K Units)
Table 27. Global Adenovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 28. Global Adenovirus Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Adenovirus Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Adenovirus Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 31. Global Adenovirus Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 32. North America Adenovirus Vaccine Sales by Country (2016-2021e) & (K Units)
Table 33. North America Adenovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. North America Adenovirus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Adenovirus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Adenovirus Vaccine Sales by Type (2016-2021e) & (K Units)
Table 37. North America Adenovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. North America Adenovirus Vaccine Sales by Application (2016-2021e) & (K Units)
Table 39. North America Adenovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 40. Europe Adenovirus Vaccine Sales by Country (2016-2021e) & (K Units)
Table 41. Europe Adenovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 42. Europe Adenovirus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Adenovirus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Adenovirus Vaccine Sales by Type (2016-2021e) & (K Units)
Table 45. Europe Adenovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Adenovirus Vaccine Sales by Application (2016-2021e) & (K Units)
Table 47. Europe Adenovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Asia-Pacific Adenovirus Vaccine Sales by Region (2016-2021e) & (K Units)
Table 49. Asia-Pacific Adenovirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 50. Asia-Pacific Adenovirus Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Adenovirus Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Adenovirus Vaccine Sales by Type (2016-2021e) & (K Units)
Table 53. Asia-Pacific Adenovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 54. Asia-Pacific Adenovirus Vaccine Sales by Application (2016-2021e) & (K Units)
Table 55. Asia-Pacific Adenovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 56. South America Adenovirus Vaccine Sales by Country (2016-2021e) & (K Units)
Table 57. South America Adenovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 58. South America Adenovirus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Adenovirus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Adenovirus Vaccine Sales by Type (2016-2021e) & (K Units)
Table 61. South America Adenovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 62. South America Adenovirus Vaccine Sales by Application (2016-2021e) & (K Units)
Table 63. South America Adenovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Adenovirus Vaccine Sales by Country (2016-2021e) & (K Units)
Table 65. Middle East & Africa Adenovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Adenovirus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Adenovirus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Adenovirus Vaccine Sales by Type (2016-2021e) & (K Units)
Table 69. Middle East & Africa Adenovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Adenovirus Vaccine Sales by Application (2016-2021e) & (K Units)
Table 71. Middle East & Africa Adenovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Adenovirus Vaccine Typical Distributors
Table 75. Adenovirus Vaccine Typical Customers
List of Figures
Figure 1. Adenovirus Vaccine Picture
Figure 2. Global Adenovirus Vaccine Sales Market Share by Type in 2020
Figure 3. Type 4 Vaccine
Figure 4. Type 7 Vaccine
Figure 5. Global Adenovirus Vaccine Sales Market Share by Application in 2020
Figure 6. Research & Academic Laboratories
Figure 7. Pharmaceutical & Biotechnology Companies
Figure 8. Others
Figure 9. Global Adenovirus Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Adenovirus Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Adenovirus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Adenovirus Vaccine Sales (2016-2026) & (K Units)
Figure 31. Global Adenovirus Vaccine Production Capacity (2016-2026) & (K Units)
Figure 32. Global Adenovirus Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Adenovirus Vaccine Market Drivers
Figure 34. Adenovirus Vaccine Market Restraints
Figure 35. Adenovirus Vaccine Market Trends
Figure 36. Global Adenovirus Vaccine Sales Market Share by Manufacturer in 2020
Figure 37. Global Adenovirus Vaccine Revenue Market Share by Manufacturer in 2020
Figure 38. Adenovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Adenovirus Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Adenovirus Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Adenovirus Vaccine Sales Market Share by Region (2016-2026)
Figure 42. Global Adenovirus Vaccine Revenue Market Share by Region (2016-2026)
Figure 43. North America Adenovirus Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Europe Adenovirus Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Adenovirus Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. South America Adenovirus Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Adenovirus Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Global Adenovirus Vaccine Sales Market Share by Type (2016-2026)
Figure 49. Global Adenovirus Vaccine Revenue Market Share by Type (2016-2026)
Figure 50. Global Adenovirus Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Adenovirus Vaccine Sales Market Share by Application (2016-2026)
Figure 52. Global Adenovirus Vaccine Revenue Market Share by Application (2016-2026)
Figure 53. Global Adenovirus Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Adenovirus Vaccine Sales Market Share by Country (2016-2026)
Figure 55. North America Adenovirus Vaccine Revenue Market Share by Country (2016-2026)
Figure 56. North America Adenovirus Vaccine Sales Market Share by Type (2016-2026)
Figure 57. North America Adenovirus Vaccine Sales Market Share by Application (2016-2026)
Figure 58. Europe Adenovirus Vaccine Sales Market Share by Country (2016-2026)
Figure 59. Europe Adenovirus Vaccine Revenue Market Share by Country (2016-2026)
Figure 60. Europe Adenovirus Vaccine Sales Market Share by Type (2016-2026)
Figure 61. Europe Adenovirus Vaccine Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Adenovirus Vaccine Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Adenovirus Vaccine Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Adenovirus Vaccine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Adenovirus Vaccine Sales Market Share by Application (2016-2026)
Figure 66. South America Adenovirus Vaccine Sales Market Share by Country (2016-2026)
Figure 67. South America Adenovirus Vaccine Revenue Market Share by Country (2016-2026)
Figure 68. South America Adenovirus Vaccine Sales Market Share by Type (2016-2026)
Figure 69. South America Adenovirus Vaccine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Adenovirus Vaccine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Adenovirus Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Adenovirus Vaccine Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Adenovirus Vaccine Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のアデノウイルスベクターワクチン市場規模・現状・予測（2021年-2027年） Adenovirus vector vaccine refers to the adenovirus as the carrier, the protective antigen gene is recombinant into the adenovirus genome, using the recombinant adenovirus can express the protective antigen gene made of vaccine.The characteristics of adenovirus vector vaccine showed that the adenovir…- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…
- 世界の新型コロナウイルス感染症DNAワクチン市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 DNA Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 DNA Vaccine status, future forecast, growth opportunity, key market, and key play…
- 世界の新型コロナウイルス感染症組換えタンパク質ワクチン市場規模・現状・予測（2021年-2027年） Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-ol…
- 世界の経口コレラワクチン市場 2021：企業別、地域別、種類・用途別 The Oral Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…